|
Apr 19
|
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split
|
|
Mar 27
|
Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential
|
|
Dec 18
|
Investors Don't See Light At End Of Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Tunnel And Push Stock Down 27%
|